$2.7M
2 filings since 2025 · latest Options filed
Maxymune Therapeutics, Inc. is a pioneering biopharmaceutical company focused on developing innovative immunotherapies aimed at treating various immune-related diseases. With a commitment to advancing patient care through scientific research and development, Maxymune strives to harness the power of the immune system to improve health outcomes.
What sets it apart
Maxymune stands out for its proprietary approaches that enhance immune system responses, setting the stage for transformational therapies in the field of immunotherapy.
Maxymune-01 is an advanced immunotherapy product designed to target specific pathways in the immune system, enhancing the body's natural ability to fight off diseases. This flagship offering is undergoing pivotal clinical trials to evaluate its safety and efficacy.
